Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.
“Although few people die of pain, many still die in pain, while even more live in pain. We will leave no stone unturned to help these patients.”
As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to people living with pain worldwide. Strong ongoing partnerships with leading healthcare and development organisations bring our new products to life. We are a fully integrated pharmaceutical company that offers support along the entire value chain – from drug development through to commercialisation.
billion euro in 2021
countries across Europe, Latin America and the US
research centres, our Research Unit in Aachen and our Innovation Hub in Boston
manufacturing sites in Europe and Latin America
Our unique commitment
Pain is a huge burden. It impacts patients – as well as their families, friends, caregivers and society as a whole. As a global leader in pain management for nearly 50 years, we are driven to seek new solutions to relieve pain.
At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact for society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.
Although firmly rooted in Germany, today we are very much a growing global business: since spreading our wings beyond Germany in the 1960s, we have continued to grow steadily.
In our quest to improve the lives of even more patients in need, we enrich our expertise in pain management with a complementary diversification into devices and technologies.